Español Inglés
Acceso usuarios

Documentación Coronavirus

Supportive care in patients with cancer during the COVID-19 pandemic

16-06-2021

Cancer care has been profoundly impacted by the global pandemic of severe acute respiratory syndrome coronavirus 2 disease (coronavirus disease 2019, COVID-19), resulting in unprecedented challenges. Supportive care is an essential component of cancer treatment, seeking to prevent and manage chemotherapy complications such as febrile neutropenia, anaemia, thrombocytopenia/bleeding, thromboembolic events and nausea/vomiting, all of which are common causes of hospitalisation. These adverse events are an essential consideration under routine patient management, but particularly so during a pandemic, a setting in which clinicians aim to minimise patients' risk of infection and need for hospital visits. Professional medical oncology societies have been providing updated guidelines to support health care professionals with the management, treatment and supportive care needs of their patients with cancer under the threat of COVID-19. This paper aims to review the recommendations made by the most prominent medical oncology societies for devising and modifying supportive care strategies during the pandemic.

The COVID-19 pandemic: An opportunity to rethink and harmonise the frequency of follow-up visits for patients with early stage breast cancer

09-06-2021

While routine, in-person follow-up of early-stage breast cancer patients (EBC) after completion of initial treatment is common, the COVID-19 pandemic has resulted in unprecedented changes in clinical practice. A systematic review was performed to evaluate the evidence supporting different frequencies of routine follow-up.

Severity of COVID-19 in patients with lung cancer: evidence and challenges

01-06-2021

Aplicación de la Inteligencia Artificial para el Diagnóstico Preoperatorio y la Predicción Pronóstica en el Cáncer Epitelial de Ovario en base a Biomarcadores Sanguíneos

Immunotherapy and Radiotherapy for Older Cancer Patients during the COVID-19 Era: Proposed Paradigm by the International Geriatric Radiotherapy Group

24-05-2021

Immunotherapy and Radiotherapy for Older Cancer Patients during the COVID-19 Era: Proposed Paradigm by the International Geriatric Radiotherapy Group

A narrative review of the pathophysiology of COVID-19 infection among cancer patients: Current evidence and research perspectives

17-05-2021

The mechanism by which a suppressed immune system of a cancer patient makes them susceptible to COVID-19 is still unclear. Any delay or discontinuation of cancer care due to the pandemic is expected to have a detrimental impact on the outcome of cancer. A few studies have addressed the incidence of COVID-19 among cancer patients, but the small sample size of such studies makes it difficult to draw inference to the general population.

A narrative review of the pathophysiology of COVID-19 infection among cancer patients: Current evidence and research perspectives

12-05-2021

The mechanism by which a suppressed immune system of a cancer patient makes them susceptible to COVID-19 is still unclear. Any delay or discontinuation of cancer care due to the pandemic is expected to have a detrimental impact on the outcome of cancer. A few studies have addressed the incidence of COVID-19 among cancer patients, but the small sample size of such studies makes it difficult to draw inference to the general population.

ACE2: At the crossroad of COVID-19 and lung cancer

05-05-2021

Gunnar Gottschalk, Konstance Knox, Avik Roy

De-escalating cancer treatments during COVID 19 pandemic: Is metronomic chemotherapy a reasonable option?

26-04-2021

Palma Fedele, Valeria Sanna, Alessandro Fancellu, Antonella Marino, Nicola Calvani, Saverio Cinieri

Cancer management during the COVID-19 pandemic: Choosing between the devil and the deep blue sea

19-04-2021

Marc Boutros, Elissar Moujaess, Hampig Raphael Kourie

Cancer treatment in the coronavirus disease pandemic

05-04-2021

Jia-Tao Zhang, Wen-Zhao Zhong, Yi-Long Wu

Changes in Treatment Behavior during the COVID-19 Pandemic among Patients at a Cancer Hospital

29-03-2021

Yasuyoshi Sato,Yu Fujiwara, Naoki Fukuda, Brian Hayama, Yoshinori Ito, Shinji Ohno, Shunji Takahashi, and on behalf of the COVID-19 Working Group of The Cancer Institute Hospital of Japanese Foundation for Cancer Research

Total pages: 8
Suggestions
Diseño y Desarrollo web Im3diA comunicación

Bienvenida/o a la información básica sobre las cookies de la página web responsabilidad de la entidad: Grupo Arán de Comunicación S.L..

Una cookie o galleta informática es un pequeño archivo de información que se guarda en tu ordenador, “smartphone” o tableta cada vez que visitas nuestra página web. Algunas cookies son nuestras y otras pertenecen a empresas externas que prestan servicios para nuestra página web.

Las cookies pueden ser de varios tipos: las cookies técnicas son necesarias para que nuestra página web pueda funcionar, no necesitan de tu autorización y son las únicas que tenemos activadas por defecto.

El resto de cookies sirven para mejorar nuestra página, para personalizarla en base a tus preferencias, o para poder mostrarte publicidad ajustada a tus búsquedas, gustos e intereses personales. Puedes aceptar todas estas cookies pulsando el botón ACEPTA TODO o configurarlas o rechazar su uso clicando en el apartado CONFIGURACIÓN DE COOKIES.

Si quires más información, consulta la “POLITICA COOKIES” de nuestra página web.